Single-cell analysis provides novel insights into elements of CAR T cell toxicities and response.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes
Journal of Hematology & Oncology Open Access 07 October 2021
Access options
Subscribe to Nature+
Get immediate online access to Nature and 55 other Nature journal
$29.99
monthly
Subscribe to Journal
Get full journal access for 1 year
$79.00
only $6.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.

References
Locke, F. L. et al. Lancet Oncol. 20, 31–42 (2019).
Schuster, S. J. et al. N. Engl. J. Med. 377, 2545–2554 (2017).
Neelapu, S. S. et al. N. Engl. J. Med. 377, 2531–2544 (2017).
Deng, Q. et al. Nat. Med. https://doi.org/10.1038/s41591-020-1061-7 (2020).
Parker, K. R. et al. Cell 183, 126–142.e117 (2020).
Eshhar, Z. in Therapeutic Antibodies. Handbook of Experimental Pharmacology Vol. 181 (eds. Chernajovsky, Y. & Nissim A.) 329–342 (Springer, Berlin, Heidelberg, 2008).
Finney, O. C. et al. J. Clin. Invest. 129, 2123–2132 (2019).
Fraietta, J. A. et al. Nat. Med. 24, 563–571 (2018).
Das, R. K., Vernau, L., Grupp, S. A. & Barrett, D. M. Cancer Discov. 9, 492–499 (2019).
Sommermeyer, D. et al. Leukemia 30, 492–500 (2016).
Locke, F. L. et al. Blood Adv. 4, 4898–4911 (2020).
Norelli, M. et al. Nat. Med. 24, 739–748 (2018).
Gust, J. et al. Cancer Discov. 7, 1404–1419 (2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Ramakrishna, S., Shah, N.N. Using single-cell analysis to predict CAR T cell outcomes. Nat Med 26, 1813–1814 (2020). https://doi.org/10.1038/s41591-020-01157-w
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-020-01157-w
This article is cited by
-
Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes
Journal of Hematology & Oncology (2021)